New findings from the Psoriasis Longitudinal Assessment and Registry (psolar) show persistency difference among biologic therapies
Persistence of STELARA® (ustekinumab) significantly better than anti-TNFs in treatment…
14 October 2014 | By Janssen
Persistence of STELARA® (ustekinumab) significantly better than anti-TNFs in treatment of psoriasis according to observational study analysis...